RxDoctor Payments Data

Sabih Iqbal, MD

Psychiatry · Miami, FLNPI 1205330024

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, AbbVie. That places this record below the midpoint for psychiatry clinicians in FL, where the typical reported total is $420.

$16in general payments, 2019–2025

Across 1 payment — averaging $15.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$16
$154,679in research payments, 2019–2025

Across 141 payments — averaging $1097.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boehringer Ingelheim International GmbH$101K
  • E.r. Squibb & Sons, L.L.C.$37K
  • AbbVie$17K

What the payments were for

  • Food & beverage$16100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie1$16

How this compares

$16 in reported general payments places this provider in the 5th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida →

Medicare billing

Part B allowed, 2024
$6,211
Medicare patients
32
Services billed
47

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Escitalopram Oxalate18$178

Paid to pharmacies, not to this prescriber.

Other psychiatry in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →